Calliditas Therapeutics AB (publ) announced the appointment of Andrew Udell as Vice President, North America Commercial, effective February 1, 2019. Mr. Udell will be part of the management team and brings over two decades of commercial and marketing experience in the biotechnology and pharmaceutical industries. Prior to joining Calliditas, Mr. Udell served as Vice President of Commercial for North America at Neuroderm Ltd. He previously served in commercial leadership roles in the biotech industry, including at Intrexon Corporation as Vice President, Marketing and Communications, and as Vice President of Marketing at Clinical Data Inc., where he was responsible for the US commercial launch of the company's product.